Page 1

Ref : Syn / CS / SE / BM / 2020-21 / January / 87 Syngene Syngene International Limited Biocon SEZ , Biocon Park , Plot No. 2 & 3 , Bommasandra Industrial Area , IV Phase , Jigani Link Road , Bengaluru 560099 , Karnataka , India . T +91 80 6891 8000 F +91 80 6891 8808 CIN : L85110KA1993PLC01493 www.syngeneintl.com January 20 , 2021 To , The Manager , BSE Limited Corporate Relationship Department Dalal Street , Mumbai - 400 001 Scrip Code : 539268 To , The Manager , National Stock Exchange of India Limited Corporate Communication Department Bandra ( EAST ) , Mumbai - 400 051 Scrip Symbol : SYNGENE Sub : Outcome of the Board Meeting Dear Sir / Madam , Pursuant to Regulations 30 and 33 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations , 2015 , we wish to inform you that the Board of Directors at its meeting held today , has considered and approved the following : Financial Results : Un - audited financial results ( consolidated and standalone ) as per Indian Accounting Standards ( Ind - AS ) for the quarter and nine months ended December 31 , 2020. A copy of the un - audited financial results along with the Limited Review Reports is enclosed herewith . The above information will also be available on the website of the Company at www.syngeneintl.com . The Board Meeting commenced at 21:03 pm and concluded at 22:44 pm . Kindly take the above information on record and acknowledge . Thanking You , Yours faithfully , For SYNGENE INTERNATIONAL LIMITED Priyadarshini Mahapatra Company Secretary & Compliance Officer Enclosed : Financial results ( consolidated and standalone ) . Limited Review Reports ( consolidated and standalone )